ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Botanical Drug Market Research Report 2026
Published Date: 2026-02-13
|
Report Code: QYRE-Auto-13I9292
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Botanical Drug Market Size Status and Forecast 2022
BUY CHAPTERS

Global Botanical Drug Market Research Report 2026

Code: QYRE-Auto-13I9292
Report
2026-02-13
Pages:119
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Buchang Pharmaceuticals
China TCM
Tsumura
Schwabe
Tong Ren Tang
Jumpcan Pharmaceutical
Guangzhou Baiyunshan Pharmaceutical
Yunnan Baiyao
Tasly Holding Group
Bionorica SE
Huarun 999
Taiji
Weleda
Kwangdong
GW Pharmaceuticals

Botanical Drug Market Size

The global Botanical Drug market was valued at US$ 38230 million in 2025 and is anticipated to reach US$ 50950 million by 2032, at a CAGR of 4.3% from 2026 to 2032.

Botanical Drug Market

Botanical Drug Market

Botanical drugs are therapeutic products derived from natural plants or their active ingredients, developed through modern pharmaceutical science, manufacturing processes, and clinical research. Compared with synthetic chemical drugs, botanical drugs feature natural origins, complex compositions, and multi-target mechanisms, representing a fusion of traditional medicine theories and modern scientific advancements. They include both traditional herbal preparations and innovative botanical-based drugs that meet international regulatory standards, with applications spanning chronic disease management, anti-infective therapies, cardiovascular care, oncology, and immunomodulation. Their development and production strictly follow GMP guidelines and advanced quality control systems to ensure consistency, efficacy, and safety. In recent years, driven by consumer preference for natural health solutions and the rise of precision medicine, botanical drugs have emerged as a key segment of the global pharmaceutical market, attracting strong policy support and investor interest.
The global botanical drug industry is experiencing growth fueled by both regulatory support and market demand. Regulatory agencies worldwide are refining herbal medicine registration standards and pharmacopoeia specifications, accelerating the globalization of botanical drugs. Rising health awareness and consumer preference for natural therapies create vast market potential. With aging populations and increasing prevalence of chronic diseases, botanical drugs are playing a vital role in cardiovascular health, diabetes care, oncology recovery, and more. Capital investment and active participation by multinational pharmaceutical companies are driving innovation, while advances in standardized extraction, active compound analysis, and intelligent manufacturing are accelerating commercialization and international market expansion.
Despite promising prospects, the botanical drug sector faces significant hurdles, including complex clinical validation, lengthy regulatory approval processes, and inconsistent quality standards. The inherent complexity of plant-based formulations requires substantial investment in R&D and quality control, particularly to meet stringent FDA and EMA approval criteria. Intellectual property protection remains a challenge, with counterfeit products impacting brand reputation and market order. Raw material costs are sensitive to environmental and climatic factors, leading to supply chain instability. Stricter regulations and trade barriers further compel companies to invest heavily in compliance, R&D, and market expansion, raising barriers to entry.
Global consumers’ growing preference for natural, sustainable, and personalized healthcare solutions is energizing the botanical drug market. Pharmaceutical companies are rapidly developing standardized botanical formulations while extending their reach into functional foods and health management products. Botanical drugs are gaining traction in hospitals, pharmacies, and online sales channels, particularly for chronic disease care, oncology support, and wellness therapies. Cross-border e-commerce and global marketing strategies are helping culturally distinctive botanical brands expand internationally. Additionally, digital health platforms, product traceability systems, and personalized medicine are shaping the transition of botanical drugs from traditional remedies to modern precision healthcare solutions.
The backbone of botanical drug manufacturing lies in diverse medicinal plant resources, with production involving cultivation, harvesting, processing, and primary extraction. Advanced cultivation methods and ecological harvesting practices have become essential for securing a stable, high-quality supply chain. Growing emphasis on sustainable farming and GAP-certified plantations has improved traceability and consistency of herbal materials. As wild harvesting faces constraints due to climate change and conservation policies, large-scale commercial cultivation has emerged in regions such as China, India, and Southeast Asia, forming global supply hubs. Progress in extraction and purification technologies is enabling standardized raw materials, supporting high-end drug development and regulatory compliance. A globalized sourcing network and modern logistics infrastructure now allow companies to better manage seasonal fluctuations and dynamic market demands.
This report delivers a comprehensive overview of the global Botanical Drug market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Botanical Drug. The Botanical Drug market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Botanical Drug market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Botanical Drug manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation

Scope of Botanical Drug Market Report

Report Metric Details
Report Name Botanical Drug Market
Accounted market size in 2025 US$ 38230 million
Forecasted market size in 2032 US$ 50950 million
CAGR 4.3%
Base Year 2025
Forecasted years 2026 - 2032
Segment by Type
  • Prescription Drug
  • OTC
Segment by Application
  • Cardiovascular
  • Tumor
  • Respiratory System
  • Other
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Buchang Pharmaceuticals, China TCM, Tsumura, Schwabe, Tong Ren Tang, Jumpcan Pharmaceutical, Guangzhou Baiyunshan Pharmaceutical, Yunnan Baiyao, Tasly Holding Group, Bionorica Se, Huarun 999, Taiji, Weleda, Kwangdong, GW Pharmaceuticals
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
  • Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
  • Chapter 3: Provides a detailed view of the competitive landscape for Botanical Drug companies, covering revenue share, development plans, and mergers and acquisitions.
  • Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
  • Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
  • Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
  • Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
  • Chapter 12: Key findings and conclusions of the report.

FAQ for this report

How fast is Botanical Drug Market growing?

Ans: The Botanical Drug Market witnessing a CAGR of 4.3% during the forecast period 2026-2032.

What is the Botanical Drug Market size in 2032?

Ans: The Botanical Drug Market size in 2032 will be US$ 50950 million.

Who are the main players in the Botanical Drug Market report?

Ans: The main players in the Botanical Drug Market are Buchang Pharmaceuticals, China TCM, Tsumura, Schwabe, Tong Ren Tang, Jumpcan Pharmaceutical, Guangzhou Baiyunshan Pharmaceutical, Yunnan Baiyao, Tasly Holding Group, Bionorica Se, Huarun 999, Taiji, Weleda, Kwangdong, GW Pharmaceuticals

What are the Application segmentation covered in the Botanical Drug Market report?

Ans: The Applications covered in the Botanical Drug Market report are Cardiovascular, Tumor, Respiratory System, Other

What are the Type segmentation covered in the Botanical Drug Market report?

Ans: The Types covered in the Botanical Drug Market report are Prescription Drug, OTC

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Botanical Drug Market Size Growth Rate by Type: 2021 vs 2025 vs 2032
1.2.2 Prescription Drug
1.2.3 OTC
1.3 Market by Application
1.3.1 Global Botanical Drug Market Growth by Application: 2021 vs 2025 vs 2032
1.3.2 Cardiovascular
1.3.3 Tumor
1.3.4 Respiratory System
1.3.5 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Botanical Drug Market Perspective (2021–2032)
2.2 Global Botanical Drug Growth Trends by Region
2.2.1 Global Botanical Drug Market Size by Region: 2021 vs 2025 vs 2032
2.2.2 Botanical Drug Historic Market Size by Region (2021–2026)
2.2.3 Botanical Drug Forecasted Market Size by Region (2027–2032)
2.3 Botanical Drug Market Dynamics
2.3.1 Botanical Drug Industry Trends
2.3.2 Botanical Drug Market Drivers
2.3.3 Botanical Drug Market Challenges
2.3.4 Botanical Drug Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Botanical Drug Players by Revenue
3.1.1 Global Top Botanical Drug Players by Revenue (2021–2026)
3.1.2 Global Botanical Drug Revenue Market Share by Players (2021–2026)
3.2 Global Top Botanical Drug Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
3.3 Global Key Players Ranking by Botanical Drug Revenue
3.4 Global Botanical Drug Market Concentration Ratio
3.4.1 Global Botanical Drug Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Botanical Drug Revenue in 2025
3.5 Global Key Players of Botanical Drug Head Offices and Areas Served
3.6 Global Key Players of Botanical Drug, Products and Applications
3.7 Global Key Players of Botanical Drug, Date of General Availability (GA)
3.8 Mergers and Acquisitions, Expansion Plans
4 Botanical Drug Breakdown Data by Type
4.1 Global Botanical Drug Historic Market Size by Type (2021–2026)
4.2 Global Botanical Drug Forecasted Market Size by Type (2027–2032)
5 Botanical Drug Breakdown Data by Application
5.1 Global Botanical Drug Historic Market Size by Application (2021–2026)
5.2 Global Botanical Drug Forecasted Market Size by Application (2027–2032)
6 North America
6.1 North America Botanical Drug Market Size (2021–2032)
6.2 North America Botanical Drug Market Growth Rate by Country: 2021 vs 2025 vs 2032
6.3 North America Botanical Drug Market Size by Country (2021–2026)
6.4 North America Botanical Drug Market Size by Country (2027–2032)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Botanical Drug Market Size (2021–2032)
7.2 Europe Botanical Drug Market Growth Rate by Country: 2021 vs 2025 vs 2032
7.3 Europe Botanical Drug Market Size by Country (2021–2026)
7.4 Europe Botanical Drug Market Size by Country (2027–2032)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Botanical Drug Market Size (2021–2032)
8.2 Asia-Pacific Botanical Drug Market Growth Rate by Region: 2021 vs 2025 vs 2032
8.3 Asia-Pacific Botanical Drug Market Size by Region (2021–2026)
8.4 Asia-Pacific Botanical Drug Market Size by Region (2027–2032)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Botanical Drug Market Size (2021–2032)
9.2 Latin America Botanical Drug Market Growth Rate by Country: 2021 vs 2025 vs 2032
9.3 Latin America Botanical Drug Market Size by Country (2021–2026)
9.4 Latin America Botanical Drug Market Size by Country (2027–2032)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Botanical Drug Market Size (2021–2032)
10.2 Middle East & Africa Botanical Drug Market Growth Rate by Country: 2021 vs 2025 vs 2032
10.3 Middle East & Africa Botanical Drug Market Size by Country (2021–2026)
10.4 Middle East & Africa Botanical Drug Market Size by Country (2027–2032)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Buchang Pharmaceuticals
11.1.1 Buchang Pharmaceuticals Company Details
11.1.2 Buchang Pharmaceuticals Business Overview
11.1.3 Buchang Pharmaceuticals Botanical Drug Introduction
11.1.4 Buchang Pharmaceuticals Revenue in Botanical Drug Business (2021–2026)
11.1.5 Buchang Pharmaceuticals Recent Development
11.2 China TCM
11.2.1 China TCM Company Details
11.2.2 China TCM Business Overview
11.2.3 China TCM Botanical Drug Introduction
11.2.4 China TCM Revenue in Botanical Drug Business (2021–2026)
11.2.5 China TCM Recent Development
11.3 Tsumura
11.3.1 Tsumura Company Details
11.3.2 Tsumura Business Overview
11.3.3 Tsumura Botanical Drug Introduction
11.3.4 Tsumura Revenue in Botanical Drug Business (2021–2026)
11.3.5 Tsumura Recent Development
11.4 Schwabe
11.4.1 Schwabe Company Details
11.4.2 Schwabe Business Overview
11.4.3 Schwabe Botanical Drug Introduction
11.4.4 Schwabe Revenue in Botanical Drug Business (2021–2026)
11.4.5 Schwabe Recent Development
11.5 Tong Ren Tang
11.5.1 Tong Ren Tang Company Details
11.5.2 Tong Ren Tang Business Overview
11.5.3 Tong Ren Tang Botanical Drug Introduction
11.5.4 Tong Ren Tang Revenue in Botanical Drug Business (2021–2026)
11.5.5 Tong Ren Tang Recent Development
11.6 Jumpcan Pharmaceutical
11.6.1 Jumpcan Pharmaceutical Company Details
11.6.2 Jumpcan Pharmaceutical Business Overview
11.6.3 Jumpcan Pharmaceutical Botanical Drug Introduction
11.6.4 Jumpcan Pharmaceutical Revenue in Botanical Drug Business (2021–2026)
11.6.5 Jumpcan Pharmaceutical Recent Development
11.7 Guangzhou Baiyunshan Pharmaceutical
11.7.1 Guangzhou Baiyunshan Pharmaceutical Company Details
11.7.2 Guangzhou Baiyunshan Pharmaceutical Business Overview
11.7.3 Guangzhou Baiyunshan Pharmaceutical Botanical Drug Introduction
11.7.4 Guangzhou Baiyunshan Pharmaceutical Revenue in Botanical Drug Business (2021–2026)
11.7.5 Guangzhou Baiyunshan Pharmaceutical Recent Development
11.8 Yunnan Baiyao
11.8.1 Yunnan Baiyao Company Details
11.8.2 Yunnan Baiyao Business Overview
11.8.3 Yunnan Baiyao Botanical Drug Introduction
11.8.4 Yunnan Baiyao Revenue in Botanical Drug Business (2021–2026)
11.8.5 Yunnan Baiyao Recent Development
11.9 Tasly Holding Group
11.9.1 Tasly Holding Group Company Details
11.9.2 Tasly Holding Group Business Overview
11.9.3 Tasly Holding Group Botanical Drug Introduction
11.9.4 Tasly Holding Group Revenue in Botanical Drug Business (2021–2026)
11.9.5 Tasly Holding Group Recent Development
11.10 Bionorica Se
11.10.1 Bionorica Se Company Details
11.10.2 Bionorica Se Business Overview
11.10.3 Bionorica Se Botanical Drug Introduction
11.10.4 Bionorica Se Revenue in Botanical Drug Business (2021–2026)
11.10.5 Bionorica Se Recent Development
11.11 Huarun 999
11.11.1 Huarun 999 Company Details
11.11.2 Huarun 999 Business Overview
11.11.3 Huarun 999 Botanical Drug Introduction
11.11.4 Huarun 999 Revenue in Botanical Drug Business (2021–2026)
11.11.5 Huarun 999 Recent Development
11.12 Taiji
11.12.1 Taiji Company Details
11.12.2 Taiji Business Overview
11.12.3 Taiji Botanical Drug Introduction
11.12.4 Taiji Revenue in Botanical Drug Business (2021–2026)
11.12.5 Taiji Recent Development
11.13 Weleda
11.13.1 Weleda Company Details
11.13.2 Weleda Business Overview
11.13.3 Weleda Botanical Drug Introduction
11.13.4 Weleda Revenue in Botanical Drug Business (2021–2026)
11.13.5 Weleda Recent Development
11.14 Kwangdong
11.14.1 Kwangdong Company Details
11.14.2 Kwangdong Business Overview
11.14.3 Kwangdong Botanical Drug Introduction
11.14.4 Kwangdong Revenue in Botanical Drug Business (2021–2026)
11.14.5 Kwangdong Recent Development
11.15 GW Pharmaceuticals
11.15.1 GW Pharmaceuticals Company Details
11.15.2 GW Pharmaceuticals Business Overview
11.15.3 GW Pharmaceuticals Botanical Drug Introduction
11.15.4 GW Pharmaceuticals Revenue in Botanical Drug Business (2021–2026)
11.15.5 GW Pharmaceuticals Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
Buchang Pharmaceuticals
China TCM
Tsumura
Schwabe
Tong Ren Tang
Jumpcan Pharmaceutical
Guangzhou Baiyunshan Pharmaceutical
Yunnan Baiyao
Tasly Holding Group
Bionorica SE
Huarun 999
Taiji
Weleda
Kwangdong
GW Pharmaceuticals
List of Tables
 Table 1. Global Botanical Drug Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
 Table 2. Key Players of Prescription Drug
 Table 3. Key Players of OTC
 Table 4. Global Botanical Drug Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
 Table 5. Global Botanical Drug Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 6. Global Botanical Drug Market Size by Region (US$ Million), 2021–2026
 Table 7. Global Botanical Drug Market Share by Region (2021–2026)
 Table 8. Global Botanical Drug Forecasted Market Size by Region (US$ Million), 2027–2032
 Table 9. Global Botanical Drug Market Share by Region (2027–2032)
 Table 10. Botanical Drug Market Trends
 Table 11. Botanical Drug Market Drivers
 Table 12. Botanical Drug Market Challenges
 Table 13. Botanical Drug Market Restraints
 Table 14. Global Botanical Drug Revenue by Players (US$ Million), 2021–2026
 Table 15. Global Botanical Drug Market Share by Players (2021–2026)
 Table 16. Global Top Botanical Drug Players by Tier (Tier 1, Tier 2, and Tier 3), based on Botanical Drug Revenue, 2025
 Table 17. Ranking of Global Top Botanical Drug Companies by Revenue (US$ Million) in 2025
 Table 18. Global 5 Largest Players Market Share by Botanical Drug Revenue (CR5 and HHI), 2021–2026
 Table 19. Global Key Players of Botanical Drug, Headquarters and Area Served
 Table 20. Global Key Players of Botanical Drug, Products and Applications
 Table 21. Global Key Players of Botanical Drug, Date of General Availability (GA)
 Table 22. Mergers and Acquisitions, Expansion Plans
 Table 23. Global Botanical Drug Market Size by Type (US$ Million), 2021–2026
 Table 24. Global Botanical Drug Revenue Market Share by Type (2021–2026)
 Table 25. Global Botanical Drug Forecasted Market Size by Type (US$ Million), 2027–2032
 Table 26. Global Botanical Drug Revenue Market Share by Type (2027–2032)
 Table 27. Global Botanical Drug Market Size by Application (US$ Million), 2021–2026
 Table 28. Global Botanical Drug Revenue Market Share by Application (2021–2026)
 Table 29. Global Botanical Drug Forecasted Market Size by Application (US$ Million), 2027–2032
 Table 30. Global Botanical Drug Revenue Market Share by Application (2027–2032)
 Table 31. North America Botanical Drug Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 32. North America Botanical Drug Market Size by Country (US$ Million), 2021–2026
 Table 33. North America Botanical Drug Market Size by Country (US$ Million), 2027–2032
 Table 34. Europe Botanical Drug Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 35. Europe Botanical Drug Market Size by Country (US$ Million), 2021–2026
 Table 36. Europe Botanical Drug Market Size by Country (US$ Million), 2027–2032
 Table 37. Asia-Pacific Botanical Drug Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 38. Asia-Pacific Botanical Drug Market Size by Region (US$ Million), 2021–2026
 Table 39. Asia-Pacific Botanical Drug Market Size by Region (US$ Million), 2027–2032
 Table 40. Latin America Botanical Drug Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 41. Latin America Botanical Drug Market Size by Country (US$ Million), 2021–2026
 Table 42. Latin America Botanical Drug Market Size by Country (US$ Million), 2027–2032
 Table 43. Middle East & Africa Botanical Drug Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 44. Middle East & Africa Botanical Drug Market Size by Country (US$ Million), 2021–2026
 Table 45. Middle East & Africa Botanical Drug Market Size by Country (US$ Million), 2027–2032
 Table 46. Buchang Pharmaceuticals Company Details
 Table 47. Buchang Pharmaceuticals Business Overview
 Table 48. Buchang Pharmaceuticals Botanical Drug Product
 Table 49. Buchang Pharmaceuticals Revenue in Botanical Drug Business (US$ Million), 2021–2026
 Table 50. Buchang Pharmaceuticals Recent Development
 Table 51. China TCM Company Details
 Table 52. China TCM Business Overview
 Table 53. China TCM Botanical Drug Product
 Table 54. China TCM Revenue in Botanical Drug Business (US$ Million), 2021–2026
 Table 55. China TCM Recent Development
 Table 56. Tsumura Company Details
 Table 57. Tsumura Business Overview
 Table 58. Tsumura Botanical Drug Product
 Table 59. Tsumura Revenue in Botanical Drug Business (US$ Million), 2021–2026
 Table 60. Tsumura Recent Development
 Table 61. Schwabe Company Details
 Table 62. Schwabe Business Overview
 Table 63. Schwabe Botanical Drug Product
 Table 64. Schwabe Revenue in Botanical Drug Business (US$ Million), 2021–2026
 Table 65. Schwabe Recent Development
 Table 66. Tong Ren Tang Company Details
 Table 67. Tong Ren Tang Business Overview
 Table 68. Tong Ren Tang Botanical Drug Product
 Table 69. Tong Ren Tang Revenue in Botanical Drug Business (US$ Million), 2021–2026
 Table 70. Tong Ren Tang Recent Development
 Table 71. Jumpcan Pharmaceutical Company Details
 Table 72. Jumpcan Pharmaceutical Business Overview
 Table 73. Jumpcan Pharmaceutical Botanical Drug Product
 Table 74. Jumpcan Pharmaceutical Revenue in Botanical Drug Business (US$ Million), 2021–2026
 Table 75. Jumpcan Pharmaceutical Recent Development
 Table 76. Guangzhou Baiyunshan Pharmaceutical Company Details
 Table 77. Guangzhou Baiyunshan Pharmaceutical Business Overview
 Table 78. Guangzhou Baiyunshan Pharmaceutical Botanical Drug Product
 Table 79. Guangzhou Baiyunshan Pharmaceutical Revenue in Botanical Drug Business (US$ Million), 2021–2026
 Table 80. Guangzhou Baiyunshan Pharmaceutical Recent Development
 Table 81. Yunnan Baiyao Company Details
 Table 82. Yunnan Baiyao Business Overview
 Table 83. Yunnan Baiyao Botanical Drug Product
 Table 84. Yunnan Baiyao Revenue in Botanical Drug Business (US$ Million), 2021–2026
 Table 85. Yunnan Baiyao Recent Development
 Table 86. Tasly Holding Group Company Details
 Table 87. Tasly Holding Group Business Overview
 Table 88. Tasly Holding Group Botanical Drug Product
 Table 89. Tasly Holding Group Revenue in Botanical Drug Business (US$ Million), 2021–2026
 Table 90. Tasly Holding Group Recent Development
 Table 91. Bionorica Se Company Details
 Table 92. Bionorica Se Business Overview
 Table 93. Bionorica Se Botanical Drug Product
 Table 94. Bionorica Se Revenue in Botanical Drug Business (US$ Million), 2021–2026
 Table 95. Bionorica Se Recent Development
 Table 96. Huarun 999 Company Details
 Table 97. Huarun 999 Business Overview
 Table 98. Huarun 999 Botanical Drug Product
 Table 99. Huarun 999 Revenue in Botanical Drug Business (US$ Million), 2021–2026
 Table 100. Huarun 999 Recent Development
 Table 101. Taiji Company Details
 Table 102. Taiji Business Overview
 Table 103. Taiji Botanical Drug Product
 Table 104. Taiji Revenue in Botanical Drug Business (US$ Million), 2021–2026
 Table 105. Taiji Recent Development
 Table 106. Weleda Company Details
 Table 107. Weleda Business Overview
 Table 108. Weleda Botanical Drug Product
 Table 109. Weleda Revenue in Botanical Drug Business (US$ Million), 2021–2026
 Table 110. Weleda Recent Development
 Table 111. Kwangdong Company Details
 Table 112. Kwangdong Business Overview
 Table 113. Kwangdong Botanical Drug Product
 Table 114. Kwangdong Revenue in Botanical Drug Business (US$ Million), 2021–2026
 Table 115. Kwangdong Recent Development
 Table 116. GW Pharmaceuticals Company Details
 Table 117. GW Pharmaceuticals Business Overview
 Table 118. GW Pharmaceuticals Botanical Drug Product
 Table 119. GW Pharmaceuticals Revenue in Botanical Drug Business (US$ Million), 2021–2026
 Table 120. GW Pharmaceuticals Recent Development
 Table 121. Research Programs/Design for This Report
 Table 122. Key Data Information from Secondary Sources
 Table 123. Key Data Information from Primary Sources
 Table 124. Authors List of This Report


List of Figures
 Figure 1. Botanical Drug Picture
 Figure 2. Global Botanical Drug Market Size Comparison by Type (US$ Million), 2021–2032
 Figure 3. Global Botanical Drug Market Share by Type: 2025 vs 2032
 Figure 4. Prescription Drug Features
 Figure 5. OTC Features
 Figure 6. Global Botanical Drug Market Size by Application (US$ Million), 2021–2032
 Figure 7. Global Botanical Drug Market Share by Application: 2025 vs 2032
 Figure 8. Cardiovascular Case Studies
 Figure 9. Tumor Case Studies
 Figure 10. Respiratory System Case Studies
 Figure 11. Other Case Studies
 Figure 12. Botanical Drug Report Years Considered
 Figure 13. Global Botanical Drug Market Size (US$ Million), Year-over-Year: 2021–2032
 Figure 14. Global Botanical Drug Market Size, (US$ Million), 2021 vs 2025 vs 2032
 Figure 15. Global Botanical Drug Market Share by Region: 2025 vs 2032
 Figure 16. Global Botanical Drug Market Share by Players in 2025
 Figure 17. Global Botanical Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
 Figure 18. The Top 10 and 5 Players Market Share by Botanical Drug Revenue in 2025
 Figure 19. North America Botanical Drug Market Size YoY Growth (US$ Million), 2021–2032
 Figure 20. North America Botanical Drug Market Share by Country (2021–2032)
 Figure 21. United States Botanical Drug Market Size YoY Growth (US$ Million), 2021–2032
 Figure 22. Canada Botanical Drug Market Size YoY Growth (US$ Million), 2021–2032
 Figure 23. Europe Botanical Drug Market Size YoY Growth (US$ Million), 2021–2032
 Figure 24. Europe Botanical Drug Market Share by Country (2021–2032)
 Figure 25. Germany Botanical Drug Market Size YoY Growth (US$ Million), 2021–2032
 Figure 26. France Botanical Drug Market Size YoY Growth (US$ Million), 2021–2032
 Figure 27. U.K. Botanical Drug Market Size YoY Growth (US$ Million), 2021–2032
 Figure 28. Italy Botanical Drug Market Size YoY Growth (US$ Million), 2021–2032
 Figure 29. Russia Botanical Drug Market Size YoY Growth (US$ Million), 2021–2032
 Figure 30. Ireland Botanical Drug Market Size YoY Growth (US$ Million), 2021–2032
 Figure 31. Asia-Pacific Botanical Drug Market Size YoY Growth (US$ Million), 2021–2032
 Figure 32. Asia-Pacific Botanical Drug Market Share by Region (2021–2032)
 Figure 33. China Botanical Drug Market Size YoY Growth (US$ Million), 2021–2032
 Figure 34. Japan Botanical Drug Market Size YoY Growth (US$ Million), 2021–2032
 Figure 35. South Korea Botanical Drug Market Size YoY Growth (US$ Million), 2021–2032
 Figure 36. Southeast Asia Botanical Drug Market Size YoY Growth (US$ Million), 2021–2032
 Figure 37. India Botanical Drug Market Size YoY Growth (US$ Million), 2021–2032
 Figure 38. Australia & New Zealand Botanical Drug Market Size YoY Growth (US$ Million), 2021–2032
 Figure 39. Latin America Botanical Drug Market Size YoY Growth (US$ Million), 2021–2032
 Figure 40. Latin America Botanical Drug Market Share by Country (2021–2032)
 Figure 41. Mexico Botanical Drug Market Size YoY Growth (US$ Million), 2021–2032
 Figure 42. Brazil Botanical Drug Market Size YoY Growth (US$ Million), 2021–2032
 Figure 43. Middle East & Africa Botanical Drug Market Size YoY Growth (US$ Million), 2021–2032
 Figure 44. Middle East & Africa Botanical Drug Market Share by Country (2021–2032)
 Figure 45. Israel Botanical Drug Market Size YoY Growth (US$ Million), 2021–2032
 Figure 46. Saudi Arabia Botanical Drug Market Size YoY Growth (US$ Million), 2021–2032
 Figure 47. UAE Botanical Drug Market Size YoY Growth (US$ Million), 2021–2032
 Figure 48. Buchang Pharmaceuticals Revenue Growth Rate in Botanical Drug Business (2021–2026)
 Figure 49. China TCM Revenue Growth Rate in Botanical Drug Business (2021–2026)
 Figure 50. Tsumura Revenue Growth Rate in Botanical Drug Business (2021–2026)
 Figure 51. Schwabe Revenue Growth Rate in Botanical Drug Business (2021–2026)
 Figure 52. Tong Ren Tang Revenue Growth Rate in Botanical Drug Business (2021–2026)
 Figure 53. Jumpcan Pharmaceutical Revenue Growth Rate in Botanical Drug Business (2021–2026)
 Figure 54. Guangzhou Baiyunshan Pharmaceutical Revenue Growth Rate in Botanical Drug Business (2021–2026)
 Figure 55. Yunnan Baiyao Revenue Growth Rate in Botanical Drug Business (2021–2026)
 Figure 56. Tasly Holding Group Revenue Growth Rate in Botanical Drug Business (2021–2026)
 Figure 57. Bionorica Se Revenue Growth Rate in Botanical Drug Business (2021–2026)
 Figure 58. Huarun 999 Revenue Growth Rate in Botanical Drug Business (2021–2026)
 Figure 59. Taiji Revenue Growth Rate in Botanical Drug Business (2021–2026)
 Figure 60. Weleda Revenue Growth Rate in Botanical Drug Business (2021–2026)
 Figure 61. Kwangdong Revenue Growth Rate in Botanical Drug Business (2021–2026)
 Figure 62. GW Pharmaceuticals Revenue Growth Rate in Botanical Drug Business (2021–2026)
 Figure 63. Bottom-up and Top-down Approaches for This Report
 Figure 64. Data Triangulation
 Figure 65. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Novocure

SIMILAR REPORTS

Botanical and Plant Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Botanical and Herbal Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Botanical Medicine Market Research Report 2024
Botanical and Plant Derivative Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Botanical Supplement and Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Plant Derivative Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Botanical Dietary Supplement Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Plant Extract Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Plant Based Supplement Market Research Report 2024
Global Herbal Medicinal Products Market Size Manufacturers Supply Chain Sales Channel and Clients 2024 2030
Botanical Extracts Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global OTC Herbal and Traditional Medicines Market Insights Forecast to 2030
Global Botanical Plant Derived Drug Market Research Report 2025
Global Herbal Supplements and Medicine Market Research Report 2024
Global Botanical Ingredient Market Research Report 2024
Global Botanical Sugar Market Research Report 2024
Global Dietary Supplement Ingredient Market Research Report 2024
Global Botanical Infused Drink Market Research Report 2024
Global Herbal Medicine Market Insights Forecast to 2030
Global Plant based Beauty Products Market Research Report 2024
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions